tradingkey.logo
tradingkey.logo
Buscar

Aeluma Ord Shs

ALMU
Añadir a la lista de seguimiento
7.540USD
-0.500-6.22%
Cierre 10-30 16:00(ET)
145.60MCap. mercado
PérdidaP/E TTM

Acerca de Aeluma Ord Shs Compañía

Aeluma, Inc. is a semiconductor company that focuses on photonic and electronic technologies that are designed for scalability. It is engaged in developing semiconductors for sensing, communication, and computing applications. The Company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Its technology is used in mobile, artificial intelligence (AI), defense and aerospace, robotics, automotive, augmented reality/virtual reality (AR/VR), industrial automation, machine vision, robotics, defense & aerospace, three-dimensional (3D) imaging, telecommunications, and quantum. The Company operates research and development (R&D) and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test, and validation. It also partners with production-scale fabrication foundries, packaging, and integration companies.

Perfil de Aeluma Ord Shs

Símbolo de cotización- -
Nombre de la empresa- -
Fecha de salida a bolsa- -
Director ejecutivo- -
Número de empleados- -
Tipo de seguridad- -
Fin del año fiscal- -
Dirección- -
Ciudad- -
Bolsa de valores- -
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotización- -
Fecha de salida a bolsa- -
Director ejecutivo- -

Ejecutivos de Aeluma Ord Shs

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jonathan Klamkin, Ph.D.
Mr. Jonathan Klamkin, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.24M
+99.81%
Mr. Jonathan Klamkin, Ph.D.
Mr. Jonathan Klamkin, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.24M
+99.81%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
21.55K
-8.40%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
21.55K
-8.40%
Mr. Christopher P. (Chris) Stewart
Mr. Christopher P. (Chris) Stewart
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
12.78K
--
Mr. Christopher P. (Chris) Stewart
Mr. Christopher P. (Chris) Stewart
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
12.78K
--
Prof. Steven P. DenBaars
Prof. Steven P. DenBaars
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Byron
Mr. Michael (Mike) Byron
Independent Director
Independent Director
--
--
Mr. Craig Ensley
Mr. Craig Ensley
Independent Director
Independent Director
--
--
Ms. Moira Conlon
Ms. Moira Conlon
Investor Relations
Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jonathan Klamkin, Ph.D.
Mr. Jonathan Klamkin, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.24M
+99.81%
Mr. Jonathan Klamkin, Ph.D.
Mr. Jonathan Klamkin, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.24M
+99.81%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
21.55K
-8.40%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
21.55K
-8.40%
Mr. Christopher P. (Chris) Stewart
Mr. Christopher P. (Chris) Stewart
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
12.78K
--
Mr. Christopher P. (Chris) Stewart
Mr. Christopher P. (Chris) Stewart
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
12.78K
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Aeluma Ord Shs?

Los cinco principales accionistas de Aeluma Ord Shs son: Mr. Jonathan Klamkin, Ph.D.
tradingkey.logo
Advertencia de Riesgo: Nuestro sitio web y aplicación móvil solo proporcionan información general sobre ciertos productos de inversión. Finsights no proporciona, y la provisión de dicha información no debe interpretarse como que Finsights proporciona, asesoramiento financiero o recomendación para cualquier producto de inversión.
Los productos de inversión están sujetos a riesgos de inversión significativos, incluida la posible pérdida del monto principal invertido y pueden no ser adecuados para todos. El rendimiento pasado de los productos de inversión no es indicativo de su rendimiento futuro.
Finsights puede permitir que anunciantes o afiliados de terceros coloquen o entreguen anuncios en nuestro sitio web o aplicación móvil o en cualquier parte de los mismos y puede ser compensado por ellos en función de su interacción con los anuncios.
© Derechos de autor: FINSIGHTS MEDIA PTE. LTD. Todos los derechos reservados.